Provided by Tiger Fintech (Singapore) Pte. Ltd.

Macrogenics

1.21
+0.02001.68%
Volume:716.59K
Turnover:877.76K
Market Cap:76.34M
PE:-1.36
High:1.27
Open:1.23
Low:1.20
Close:1.19
Loading ...

MacroGenics, Inc. (NASDAQ:MGNX) Looks Inexpensive After Falling 42% But Perhaps Not Attractive Enough

Simply Wall St.
·
14 Apr

908 Devices Leads These 3 Penny Stocks To Consider

Simply Wall St.
·
10 Apr

MacroGenics, Inc. : H.c. Wainwright Cuts Target Price to $2 From $4

THOMSON REUTERS
·
25 Mar

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)

TIPRANKS
·
25 Mar

MacroGenics (MGNX) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
21 Mar

Barclays Sticks to Their Buy Rating for MacroGenics (MGNX)

TIPRANKS
·
21 Mar

Macrogenics Inc (MGNX) Q4 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses

GuruFocus.com
·
21 Mar

MacroGenics (MGNX) Gets a Hold from TD Cowen

TIPRANKS
·
21 Mar

MacroGenics (MGNX) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
21 Mar

MacroGenics (MGNX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
21 Mar

MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
21 Mar

MacroGenics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

BRIEF-MacroGenics Inc Provides Update On Corporate Progress And 2024 Financial Results

Reuters
·
21 Mar

MacroGenics 2024 EPS $(1.07) Down From $(0.15) YoY

Benzinga
·
21 Mar

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results

THOMSON REUTERS
·
21 Mar

Press Release: MacroGenics Provides Update on Corporate Progress and 2024 Financial Results

Dow Jones
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

MacroGenics Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
19 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

GlobeNewswire
·
06 Mar